advertisement

WGA Rescources

Agarwal R 10

Showing records 1 to 10 | Display all abstracts from Agarwal R

100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Hann Yih T
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Lambuk L
Frontiers in pharmacology 2022; 13: 875662
100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Abd Ghapor AA
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohd Lazaldin MA; Ahmad S
Frontiers in pharmacology 2022; 13: 875662
100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Agarwal R
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Iezhitsa I
Frontiers in pharmacology 2022; 13: 875662
100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Razali N; Iezhitsa I
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Agarwal R; Uskoković V
Frontiers in pharmacology 2022; 13: 875662
100616 Effect of trans-resveratrol on glutamate clearance and visual behaviour in rats with glutamate induced retinal injury
Mohd Ismail N
Experimental Eye Research 2022; 220: 109104
100809 Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Mohamud R; Mohamud R
Frontiers in pharmacology 2022; 13: 875662

Issue 23-1

Change Issue


advertisement

Oculus